Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model
Cystische Fibrose Learning Network Telehealth Innovation Lab während der COVID-19-Pandemie: Auswirkungen auf den Zugang zur Versorgung, Outcomes und ein neues CF-Versorgungsmodell
Pediatric Pulmonology · 2025-05 · 60 (5)
DOI: 10.1002/ppul.71102 ↗Auf einen Blick
Bei Menschen mit zystischer Fibrose war im CFLN TH-iLab die Telehealth-Nutzung höher als in den Vergleichsgruppen. Klinische Outcomes blieben dabei ähnlich.
Fragestellung
Ist eine standardisierte Telehealth-Implementierung im CFLN TH-iLab mit besserem Zugang zur CF-Versorgung und ähnlichen Lungenfunktions- und Ernährungsoutcomes verbunden?
Methode
Auswertung aller Personen mit CF im CF Foundation Registry von 1/2020 bis 12/2021; Vergleich von CFLN TH-iLab, CFLN TH-iLab-Non-Teilnehmenden und Nicht-CFLN-Programmen.
Ergebnisse
2020 und 2021 waren die mittlere Zahl der Telehealth-Besuche pro Person/Jahr und der Anteil mit ≥1 Telehealth-Besuch im CFLN TH-iLab höher. Lungenfunktion, Anthropometrie, Spirometrie und Kulturen waren ähnlich.
Schlussfolgerung der Autor:innen
Die Integration von Telehealth in die CF-Versorgung im CFLN TH-iLab ermöglichte während der COVID-19-Pandemie Zugang zur Versorgung, ohne klinische Outcomes zu beeinträchtigen.
Kernaussagen
- Telehealth-Nutzung war im CFLN TH-iLab höher als in den Vergleichsgruppen.
- Klinische Outcomes blieben zwischen den Gruppen ähnlich.
- Zugang zur interdisziplinären Versorgung war im CFLN Non-TH-iLab am höchsten.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 05.05.2025. Verfasst von Dana Albon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, COVID-19, Telemedicine, Health Services Accessibility. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was grant support by CFF 004212322 - Albon; CFF SEID19AB0., Cystic Fibrosis Foundation.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
Cystic fibrosis (CF) is a chronic genetic disorder requiring regimented visits for maintenance of care. The COVID‐19 pandemic accelerated the accessibility of telehealth (TH) and forced a trial of incorporating remote care into routine CF care. The CF Learning Network (CFLN) organized for data sharing into a telehealth innovation lab (TH‐iLab) to improve access to the interdisciplinary care team and co‐produced shared agenda‐setting.
Methods
All persons with CF (PwCF) with a CF diagnosis in the CF Foundation Registry (CFFPR) from 1/2020–12/2021 were included and categorized into CFLN TH‐iLab, CFLN TH‐iLab non‐participants, and non‐CFLN programs. Hypothesis: standardized TH implementation in the CFLN TH‐iLab is associated with increased access to the CF care model and results in similar lung function and nutrition health outcomes.
Results
In 2020 and 2021, the average number of TH visits per person per year and the percentage of PwCF with one or more TH visits per year were higher in the CFLN TH‐iLab than in the other groups. Lung function was highest in PwCF, followed by a program that was part of the CFLN TH‐iLab in 2020 and 2021. Anthropometric measurements, spirometry, and attainment of microbiology cultures were similar among all three groups. Access to interdisciplinary care was highest in the CFLN non‐TH‐iLab group.
Conclusion
Integrating TH into CF care in the CFLN TH‐iLab provided access to care during the COVID‐19 pandemic without compromising clinical outcomes. Further research on optimizing the telehealth experience for PwCF can help better understand TH's long‐term impact on CF care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.
- Seattle Children's Hospital, Pulmonary and Sleep Medicine, University of Washington School of Medicine, Pediatrics, Seattle, Washington, USA.
- Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Department of Pediatrics, The University of Utah, Salt Lake City, Utah, USA.
- Virginia Commonwealth University, Pulmonary and Critical Care, Richmond, Virginia, USA.
Förderung
- This study was grant support by CFF 004212322 - Albon; CFF SEID19AB0.
- Cystic Fibrosis Foundation
Zitieren
APA
Albon, D., Ong, T., Horton, B., Brighton, D., Shen, S., List, R., Antos, N., Asfour, F., Balasa, E., Beachler, D., Daines, C., Froh, D., Kier, C., Nasr, S., Sathe, M., Sawicki, G., Schechter, M., Solomon, G., & Powers, M. (2025). Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric Pulmonology, 60(5). https://doi.org/10.1002/ppul.71102
Vancouver
Albon D, Ong T, Horton B, Brighton D, Shen S, List R, et al. Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model. Pediatric Pulmonology. 2025;60(5). doi:10.1002/ppul.71102
BibTeX
@article{Albon2025,
author = {Albon, Dana and Ong, Thida and Horton, Bethany and Brighton, David and Shen, Shiyi and List, Rhonda and Antos, Nicholas and Asfour, Fadi and Balasa, Ella and Beachler, Danielle and Daines, Cori and Froh, Deborah and Kier, Catherine and Nasr, Samya and Sathe, Meghana and Sawicki, Gregory and Schechter, Michael and Solomon, George and Powers, Michael},
title = {Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID‐19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model},
journal = {Pediatric Pulmonology},
year = {2025},
volume = {60},
number = {5},
doi = {10.1002/ppul.71102}
}
EUVIMED